COMMUNIQUÉS West-GlobeNewswire

Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
29/05/2026
LONDON, May 29, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in fireside chats at the following investor conferences in June: 2026 [...]
Jade Biosciences to Host Conference Call and Webcast on June 1, 2026, at 8:00 a.m. ET to Discuss Interim Phase 1 Healthy Volunteer Results for JADE101, a Novel, Potentially Best-in-Class Anti-APRIL Monoclonal Antibody in Development for IgA Nephropathy
29/05/2026
SAN FRANCISCO and VANCOUVER, British Columbia, May 29, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (the “Company” or “Jade”) (Nasdaq: JBIO), a clinical-stage biotechnology company focused on developing best-in-class [...]
Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons
29/05/2026
Company Announcement COPENHAGEN, Denmark; May 29, 2026 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses [...]
ASAP Dental Care Expands Evening and Weekend Hours Across Greater Jacksonville to Meet Urgent Dental and Emergency Needs
29/05/2026
ASAP Dental Care has officially announced the expansion of its evening and weekend hours across multiple locations Jacksonville, FL, May 29, 2026 (GLOBE NEWSWIRE) -- ASAP Dental Care, a leading provider of comprehensive [...]
MannKind to Host Conference Call Today to Discuss Afrezza Pediatric Approval
29/05/2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 29, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) announced today that management will host a conference call to discuss the recent FDA approval of Afrezza [...]
FDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer Drugs
29/05/2026
Streamlined approach could reduce time and cost to bring new cancer drugs into human trials Silver Spring, Md., May 29, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today issued a draft guidance to [...]
Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema
29/05/2026
The primary endpoint of mean change in best corrected visual acuity (BCVA) from baseline to week 52 in both Phase 3 trials was not met The secondary endpoint of retinal thickness showed a substantial and persistent [...]
Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema
29/05/2026
ZUG, Switzerland, May 29, 2026 (GLOBE NEWSWIRE) -- The primary endpoint of mean change in best corrected visual acuity (BCVA) from baseline to week 52 in both Phase 3 trials was not met The secondary endpoint of retinal [...]
Kun Peng International Ltd. Announces 1-for-10 Reverse Stock Split
29/05/2026
BEIJING, CHINA, May 29, 2026 (GLOBE NEWSWIRE) -- Kun Peng International Ltd. (OTCQB: KPEA) (the “Company”) announced today that a 1-for-ten (1:10) reverse split of its $0.0001 par value common stock (the “Reverse Stock [...]
MannKind Announces FDA Approval of Afrezza®, the First and Only Inhaled Mealtime Insulin for Use in Children and Adolescents Aged 6 and Older Living with Diabetes
29/05/2026
Enables dosing at the start of a meal, offering flexibility for children and adolescents as they manage school, sports, meals, and snacks throughout the day Approval advances pediatric diabetes care by introducing a new [...]
ALK to present at the Jefferies Global Healthcare Conference in New York
29/05/2026
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) today announced that the company’s Executive Vice President and CFO, Claus Steensen Sølje, is scheduled to present at the 2026 Jefferies Global Healthcare Conference in New York [...]
Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain Listing
29/05/2026
SINGAPORE, May 29, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings ( Cayman ) Limited ( Nasdaq: CUPR ) (“ Cuprina ” or “ the Company ”), a biomedical company developing and marketing products for the chronic wounds, [...]
Ipsen annonce le lancement d'une opération d’actionnariat salarié
29/05/2026
Ipsen annonce le lancement d'une opération d’actionnariat salarié PARIS, FRANCE, 29 MAI 2026 - Ipsen (Euronext : IPN ; ADR : IPSEY), annonce aujourd’hui le lancement d'une opération d’actionnariat salarié. Cette 5 ème [...]
Ipsen announces the launch of an Employee Shareholding Plan
29/05/2026
Ipsen announces the launch of an employee shareholding plan PARIS, FRANCE, 29 MAY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today the launch of an employee shareholding plan. This fifth transaction in the last [...]
Moleculin Presents ASCO 2026 Data Demonstrating No Detectable Cardiotoxicity with Annamycin Despite Exposure Levels Far Exceeding Conventional Anthracycline Limits
29/05/2026
Independent Cleveland Clinic Cardiac Review Supports Potential Best-in-Class Safety Profile as MIRACLE Phase 2b/3 Trial Advances HOUSTON, May 29, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“ [...]
Bioxytran Highlights New Book on Real-Time Monitoring Tissue Oxygenation Relevant to Oxygen Carrier BXT-25
29/05/2026
Brain tissue oxygenation in early stage of stroke with BXT-25 is monitored in real time BOSTON, MASSACHUSETTS, May 29, 2026 (GLOBE NEWSWIRE) -- Bioxytran Inc. (OTCQB: BIXT), a biotechnology company developing [...]
PICARD MEDICAL, INC. Issues Letter to Shareholders
29/05/2026
TUCSON, Ariz., May 29, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the “Company” or “Picard Medical”), parent company of SynCardia Systems LLC, maker of the world’s first and only total [...]
PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026
29/05/2026
DELRAY BEACH, Fla., May 29, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) today announced it will report financial results for the fourth quarter and fiscal [...]
Omniscient Secures USD 27.2M Series D to Accelerate Commercialization of AI-Enabled Brain Technology
29/05/2026
Funding to scale FDA-cleared Quicktome® platform and drive next-generation personalized brain care globally SAN FRANCISCO, May 29, 2026 (GLOBE NEWSWIRE) -- Omniscient (o8t®), a pioneer in AI-driven brain analysis [...]

Pages